Market Tracker

02/10 5:36am ET

Ocata Therapeutics Inc (NASDAQ:OCAT)

8.47
Delayed Data
As of Feb 09
 +0.01 / +0.12%
Today’s Change
3.06
Today|||52-Week Range
8.71
+0.59%
Year-to-Date
No recent news for Ocata Therapeutics Inc.

Today’s Trading

Previous close8.46
Today’s open8.47
Day’s range8.45 - 8.48
Volume1,117,445
Average volume (3 months)761,999
Market cap$357.9M
Dividend yield--
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)-17.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-29.83%
P/E ratioNM
Price/Sales1,206.25
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MRTXMirati Therapeutics ...+0.12+0.64%
ARNAArena Pharmaceutical...+0.02+1.33%
FLMLFlamel Technologies ...+0.06+0.65%
VNDAVanda Pharmaceutical...-0.03-0.37%
Data as of 02/09/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$157.9K
Annual profit (last year)-$34.7M
Net profit margin-22,010.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul K. Wotton
Chief Operating &
Financial Officer
Edward H. Myles
Corporate headquarters
Marlborough, Massachusetts

Forecasts